Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dementia
Biotech
BioXcel to halve head count, narrow R&D as cash runway crumbles
Unlikely to meet requirements for a cash infusion, the biotech is laying off almost 60% of its staff to keep going through the middle of next year.
Nick Paul Taylor
Aug 14, 2023 8:44am
New Eisai collab aims to develop digital tools for dementia
Jun 29, 2023 10:33am
Coya deems dementia drug R&D plan 'premature,' switches focus
Jun 12, 2023 9:00am
Wave's ALS-dementia drug crashes out after early-phase flop
May 23, 2023 9:30am
HIV drug staves off dementia, Huntington's proteins in mice
May 1, 2023 7:00am
EIP fuses with Diffusion to get ex-Vertex drug to dementia data
Mar 30, 2023 8:12am
